Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
about
Pharmacokinetic Properties of Adenosine Amine Congener in Cochlear Perilymph after Systemic AdministrationAnimal models of substance abuse and addiction: implications for science, animal welfare, and societyComprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 1: volume of distribution at steady state.Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 2: clearance.Prediction of human clearance based on animal data and molecular properties.Recent advances in pharmacokinetic extrapolation from preclinical data to humans.Interaction of carbamazepine with herbs, dietary supplements, and food: a systematic reviewApproaches for predicting human pharmacokinetics using interspecies pharmacokinetic scaling.Modulation of the pharmacokinetics, therapeutic and adverse effects of NSAIDs by Chinese herbal medicines.A systematic analysis of physicochemical and ADME properties of all small molecule kinase inhibitors approved by US FDA from January 2001 to October 2015.Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels.Human microdose evaluation of the novel EP1 receptor antagonist GSK269984A.Estimation of human drug clearance using multiexponential techniques.New coumarin-based anti-inflammatory drug: putative antagonist of the integrins alphaLbeta2 and alphaMbeta2.Interspecies scaling: prediction of human biliary clearance and comparison with QSPKR.Non-clinical evaluation of the metabolism, pharmacokinetics and excretion of S-777469, a new cannabinoid receptor 2 selective agonist.
P2860
Q30363358-F8E9B6D6-274C-425D-B7E5-D092770B54A5Q30433958-4E549640-D5BA-4EA2-B17C-9B89C4549412Q30593572-13712D69-B2AE-43A2-A68F-18AAC235E6E3Q30593578-5AFD8EC3-E17A-4555-995D-4CF625CE8AC6Q30924298-55FE39F5-2718-4428-A576-1F0628394F28Q31049599-75ED9164-410E-43A6-9955-15CA887EFFB0Q37139662-31008ACF-873D-4125-8A8E-1B13567E494CQ37964570-0DA5BCE5-060E-4D5D-992C-DEC842E2ADAAQ38259360-95C386A1-6E5C-4256-AD2F-ED11B18BFCFFQ38763312-ADAB27CD-3E62-4DF4-935B-1CBBB32C539CQ39805145-205D2C4D-6634-4779-9C4F-3EB8526466D8Q39984138-4123D9DA-A50A-470C-9057-46E98639EA01Q41906250-138856C5-2AB1-4038-8B0B-3AC5956E5F61Q43548556-22782DEB-DD8B-4AB3-96B5-D57A50AB997BQ46289432-4D6BEFB2-47A6-4F08-8A5B-1E59910EE8E8Q46973990-3584B1CD-6D38-48CF-B1EB-D90753EA8A8AQ50739197-DBC8E4C1-3C7E-42FB-A802-444E5E267E2A
P2860
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Extrapolation of human pharmac ...... rapolative success or failure.
@ast
Extrapolation of human pharmac ...... rapolative success or failure.
@en
type
label
Extrapolation of human pharmac ...... rapolative success or failure.
@ast
Extrapolation of human pharmac ...... rapolative success or failure.
@en
prefLabel
Extrapolation of human pharmac ...... rapolative success or failure.
@ast
Extrapolation of human pharmac ...... rapolative success or failure.
@en
P356
P1476
Extrapolation of human pharmac ...... rapolative success or failure.
@en
P2093
Keith W Ward
Larry J Jolivette
P304
P356
10.1002/JPS.20373
P407
P577
2005-07-01T00:00:00Z